VEGFA and diabetic retinopathy: Indeed, a study involving a cancer model showed that forskolin’s activation of the cAMP/PKA pathway could have an inhibitory effect on vascular endothelial growth factor (VEGF) production, a key driver of retinal angiogenesis in pathologies like diabetic retinopathy [157].